Jpmorgan Chase & CO Spring Works Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 255,052 shares of SWTX stock, worth $9.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

255,052

Previous 280,126 8.95%

Holding current value

$9.95 Million

Previous $10.6 Million 22.56%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$32.04 - $42.76 $803,370 - $1.07 Million	-25,074 Reduced 8.95%	255,052 $8.17 Million
Q2 2024 Aug 12, 2024	SELL	$36.06 - $47.62 $9.48 Million - $12.5 Million	-262,907 Reduced 48.41%	280,126 $10.6 Million
Q1 2024 May 10, 2024	SELL	$36.5 - $52.5 $2.63 Million - $3.79 Million	-72,189 Reduced 11.73%	543,033 $26.7 Million
Q4 2023 Feb 12, 2024	BUY	$18.94 - $37.24 $914,764 - $1.8 Million	48,298 Added 8.52%	615,222 $22.5 Million
Q3 2023 Nov 14, 2023	SELL	$23.12 - $31.38 $718,615 - $975,353	-31,082 Reduced 5.2%	566,924 $13.1 Million
Q2 2023 Aug 11, 2023	BUY	$23.15 - $32.71 $4.42 Million - $6.24 Million	190,898 Added 46.89%	598,006 $15.7 Million
Q1 2023 May 18, 2023	BUY	$24.97 - $34.05 $1.23 Million - $1.68 Million	49,282 Added 13.77%	407,108 $10.5 Million
Q1 2023 May 11, 2023	SELL	$24.97 - $34.05 $2.3 Million - $3.14 Million	-92,101 Reduced 20.47%	357,826 $9.21 Million
Q4 2022 Feb 13, 2023	BUY	$21.73 - $28.72 $1.38 Million - $1.83 Million	63,585 Added 16.46%	449,927 $11.7 Million
Q3 2022 Nov 14, 2022	SELL	$24.1 - $39.66 $3.39 Million - $5.57 Million	-140,487 Reduced 26.67%	386,342 $11 Million
Q2 2022 Aug 11, 2022	BUY	$18.36 - $60.07 $8.12 Million - $26.6 Million	442,164 Added 522.25%	526,829 $13 Million
Q1 2022 May 11, 2022	BUY	$48.97 - $65.46 $3.05 Million - $4.08 Million	62,298 Added 278.53%	84,665 $4.78 Million
Q4 2021 Feb 10, 2022	BUY	$53.3 - $75.84 $105,693 - $150,390	1,983 Added 9.73%	22,367 $1.39 Million
Q3 2021 Nov 12, 2021	BUY	$62.66 - $88.26 $1.28 Million - $1.8 Million	20,384 New	20,384 $1.29 Million

Others Institutions Holding SWTX

# of Institutions

238

Shares Held

69.8M

Call Options Held

144K

Put Options Held

257K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.43B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Spring Works Therapeutics, Inc. Transaction History